Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Fp MDPI and FS MDPI in Persistent Asthma
NCT02175771Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray, salmeterol in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2014; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02175771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175771.